Around half of women diagnosed with ovarian cancer are over the age of 65. Older women may have different medical and social problems than those seen in younger women. This may result in them being offered less intensive chemotherapy options to treat their ovarian cancer. Research has already shown that in older people who don’t have cancer, und…

The study aims to find out the answers to the following questions: Is one of these treatment approaches better than the other? Which treatment causes fewer side effects? Which treatment offers a better quality of life? Is it safe to use bevacizumab to treat women who are having surgery at the same time as chemotherapy? If you take …